Artwork
iconShare
 
Manage episode 516795462 series 3698815
Content provided by Niraj Sharma and Niraj Sharma MD FACC FHRS. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Niraj Sharma and Niraj Sharma MD FACC FHRS or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this inaugural episode, Dr. Niraj Sharma breaks down three pivotal studies that could shift daily EP practice:

  • How high-normal potassium targeting can reduce VT burden (POT-CAST trial).
  • When GDMT withdrawal may be safe after recovery from tachycardia-induced cardiomyopathy.
  • Why adverse pregnancy outcomes may predict long-term AF risk.

Get the signal — not the noise — with expert analysis, clinical context, and practical takeaways for the EP lab.

  continue reading

3 episodes